Marken Inaugurates New Branches in India

Marken Inaugurates New Branches in India
New Delhi joins new offices in Pune, Hyderabad and Bangalore to augment Marken's India capabilities

PARIS, March 9, 2012 /PRNewswire via COMTEX/ -- Marken continues their expansion of services in India, by augmenting their existing Mumbai facility with four additional branches to support the growing demand in clinical trial logistics within India. The expansion in New Delhi, Hyderabad, Pune and Bangalore will support the growing need for temperature controlled logistics of sensitive drugs and cold chain specimens. As part of their expansion in India, Marken recently ran a special client Awareness workshop on the air transport of infectious substances.

Marken is implementing their stated plan to build the most advanced, fit for purpose clinical Supply chain network to serve the pharmaceutical community. The new India offices build on Marken's current clinical trial support services and enable the company to grow from its current industry-leading life sciences logistics platform. Marken is expanding their reach throughout India to support their clients' rapidly increasing demand for supply chain management services of Active Pharmaceutical Ingredients (API), Investigational Medical Products (IMPs) and Clinical Trial Specimens.

"The expansion of our operations in India enables Marken to better support our clients' need for regional expertise and temperature controlled supply chain services," said Wes Wheeler, Marken's Chief Executive Officer. "We have seen steady growth and demand of our specimen logistics, drug distribution and API supply chain services in India."

Marken is currently developing a new purpose-built GMP compliant depot in Bangalore due to be complete by the end of 2012. The Bangalore Depot will join Marken's already operational Argentina, Mexico and Singapore depots offering the full range of temperature controlled storage capabilities including: controlled ambient, refrigerated and frozen as Pharmaceuticals and Medical devices. Each of Marken's depots provides drug and equipment distribution solutions including: Pick & Pack, relabeling services, reverse logistics, reconciliation and certified destruction. Additionally, the network manages specimen kit distribution, interim specimen storage and management.

About Marken

Marken is the leading global clinical supply chain service provider dedicated to the pharmaceutical and life sciences industries, supporting over 6,000 investigator sites in more than 100 countries. With decades of experience in the logistics, transport and distribution of temperature sensitive life saving pharmaceuticals, clinical trial supplies and specimen collection; Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.

SOURCE Marken

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.